immunosuppression


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to immunosuppression: Immunosuppressive drugs

im·mu·no·sup·pres·sion

 (ĭm′yə-nō-sə-prĕsh′ən, ĭ-myo͞o′-)
n.
Suppression of the immune response, as by drugs or radiation, in order to prevent the rejection of grafts or transplants or to control autoimmune diseases. Also called immunodepression.

im′mu·no·sup·pres′sant (-prĕs′ənt) n.
im′mu·no·sup·pressed′ (-prĕst′) adj.
im′mu·no·sup·pres′sive adj.

immunosuppression

(ˌɪmjʊnəʊsəˈprɛʃən)
n
(Medicine) medical suppression of the body's immune system, esp in order to reduce the likelihood of rejection of a transplanted organ

im•mu•no•sup•pres•sion

(ˌɪm yə noʊ səˈprɛʃ ən, ɪˌmyu-)

n.
the inhibition of the normal immune response because of disease, the administration of drugs, or surgery.
[1960–65]
im`mu•no•sup•press′, v.t. -pressed, -press•ing.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.immunosuppression - lowering the body's normal immune response to invasion by foreign substances; can be deliberate (as in lowering the immune response to prevent rejection of a transplanted organ) or incidental (as a side effect of radiotherapy or chemotherapy for cancer)
immunological disorder - a disorder of the immune system
Translations

immunosuppression

[ɪˈmjʊːnəʊsəˈpreʃən] Ninmunosupresión f

immunosuppression

n inmunosupresión f
References in periodicals archive ?
8, 2019 (HealthDay News) -- About two-thirds of patients who survive hospitalization for sepsis have persistent elevation of inflammation and immunosuppression biomarkers, which is linked to increased mortality, according to a study published online Aug.
OKARA -- A young man has been suffering from a rare disease called immunosuppression, as per his pathological reports and CT-Scan views from various diagnostic labs.
In pre-clinical studies, SC-islets were delivered into diabetic non-human primates under immunosuppression. SC-islets were infused into the portal vein to mimic planned human clinical trials.
"Demodicosis can be associated with immunosuppression. Kids with Langerhans cell histiocytosis seem to be prone to it.
Clinical data have shown the potential for FCR001 to durably free a significant proportion of living donor kidney transplant recipients from all chronic immunosuppression by 12 months after their transplant, without rejection of their transplanted organ.
Preclinical studies showed that treatment with ReLiver allows to effectively replace liver functions, decreasing mortality by three times, preventing and treating hepatic encephalopathy, and promoting liver regeneration, without the need of immunosuppression.
Healthcare company Sanofi (EURONEXT:SAN) (NASDAQ:SNY) reported on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) for Cablivi (caplacizumab-yhdp) in combination with plasma exchange and immunosuppression for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults.
Food and Drug has approved Cablivi (caplacizumab-yhdp) in combination with plasma exchange and immunosuppression for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) a rare blood disorder in adults.
Food and Drug Administration has approved Cablivi in combination with plasma exchange and immunosuppression for the treatment of acquired thrombotic thrombocytopenic purpura in adults.
However, the outcomes and effects of donations from live and deceased donors are yet to be compared, and the surgical and immunosuppression techniques will be optimised in the future.
But high rejection rates and life-threatening complications from immunosuppression have limited the success of human intestinal transplantation.
To the Editor: Regulatory T-cells (Tregs), a subset of CD4+ T-cells, have the capacity to actively suppress immune responses and play a pivotal role in sepsis-induced immunosuppression.[1] B- and T-lymphocyte attenuator (BTLA) is a co-inhibitory receptor that is known to potently inhibit CD4+ T-cell function and to block prosurvival signaling in CD4+ T-cells.[2] Tregs constitutively express BTLA.